Sulotroban

Harmonized Tariff Code:  3822.00 Hazard Statements: H351 Suspected of causing cancer. Precautionary Statements: P281-P201-P202-P308+P313-P405-P501a Use personal protective equip

Harmonized Tariff Code:  3822.00 Risk Phrases: 45 May cause cancer. Safety Phrases: 53-45 Avoid exposure - obtain special instructions before use. In case of accident or if you

Harmonized Tariff Code:  3822.00 Risk Phrases: 45 May cause cancer. Safety Phrases: 53-45 Avoid exposure - obtain special instructions before use. In case of accident or if you

Harmonized Tariff Code:  3822.00 Risk Phrases: 45 May cause cancer. Safety Phrases: 53-45 Avoid exposure - obtain special instructions before use. In case of accident or if you

Harmonized Tariff Code:  3822.00 Risk Phrases: 45 May cause cancer. Safety Phrases: 53-45 Avoid exposure - obtain special instructions before use. In case of accident or if you

Harmonized Tariff Code:  3822.00 Hazard Statements: H350 May cause cancer. Precautionary Statements: P281-P201-P202-P308+P313-P405-P501a Use personal protective equipment as req

Harmonized Tariff Code:  3822.00 Hazard Statements: H350 May cause cancer.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Sulotroban (SKF-95587: BM-13177) is a selective antagonist for thromboxane A2 receptor ( TXA2 Receptor ). Sulotroban exhibits inhibitory activity against carbocyclic thromboxane A2- and endoperoxide-induced vasoconstrictor. Sulotroban inhibits

Sulotroban (SKF-95587: BM-13177) is a selective antagonist for thromboxane A2 receptor ( TXA2 Receptor ). Sulotroban exhibits inhibitory activity against carbocyclic thromboxane A2- and endoperoxide-induced vasoconstrictor. Sulotroban inhibits